Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Cell Genesys, Inc. (Now BioSante Pharmaceuticals)

Cell Genesys was a biotechnology company that focused on the development and commercialization of novel biological therapies for patients with cancer utilizing gene therapy. Cell Genesys merged with BioSante in 2009.

Search Projects

  • Vice President, Hayward Operations
  • Head, San Diego Manufacturing
  • Senior Director, Marketing